Select Publications
Journal articles
2023, 'A qualitative study of multiple voices to inform aftercare services for older persons following self-harm', International Journal of Geriatric Psychiatry, 38, http://dx.doi.org/10.1002/gps.5876
,2022, 'A systematic review of evidence-based aftercare for older adults following self-harm', Australian and New Zealand Journal of Psychiatry, 56, pp. 1398 - 1420, http://dx.doi.org/10.1177/00048674211067165
,2022, 'Educating Crisis Supporters About Self-Harm and Suicide in Older Adults', American Journal of Geriatric Psychiatry, 30, pp. 1212 - 1220, http://dx.doi.org/10.1016/j.jagp.2021.10.006
,2021, 'In search of the holy grail of quality dying with dementia', International Psychogeriatrics, 33, pp. 1011 - 1013, http://dx.doi.org/10.1017/S1041610220003658
,2021, 'Human rights and empowerment in aged care: Restraint, consent and dying with dignity', International Journal of Environmental Research and Public Health, 18, http://dx.doi.org/10.3390/ijerph18157899
,2021, 'Australia's problem with obtaining consent for psychotropic use in older people', Internal Medicine Journal, 51, pp. 604 - 607, http://dx.doi.org/10.1111/imj.15274
,2020, 'A missed opportunity to improve practice around the use of restraints and consent in residential aged care: Limitations of the Quality of Care Amendment (Minimising the Use of Restraints) Principles 2019', Australasian Journal on Ageing, 39, pp. 292 - 296, http://dx.doi.org/10.1111/ajag.12757
,2020, 'Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project', International Psychogeriatrics, pp. 1 - 11, http://dx.doi.org/10.1017/s1041610219002011
,2019, 'Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study', International Journal of Geriatric Psychiatry, 34, pp. 1572 - 1581, http://dx.doi.org/10.1002/gps.5167
,2019, 'Nursing home “no returns” policy, when residents are discharged to the emergency department at 4 am: what does the law say?', Medical Journal of Australia, 210, pp. 381, http://dx.doi.org/10.5694/mja2.50134
,2019, 'Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia', Drugs and Aging, 36, pp. 125 - 136, http://dx.doi.org/10.1007/s40266-018-0623-6
,2019, 'Death, dying and dementia A pivotal role for the GP', Medicine Today, 20, pp. 10 - 17
,2018, 'Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study', Journal of the American Medical Directors Association, 19, pp. 592 - 600.e7, http://dx.doi.org/10.1016/j.jamda.2018.05.002
,2018, 'Critical Contextual Elements in Facilitating and Achieving Success with a Person-Centred Care Intervention to Support Antipsychotic Deprescribing for Older People in Long-Term Care', BioMed Research International, 2018, pp. 7148515, http://dx.doi.org/10.1155/2018/7148515
,2017, 'Halting Antipsychotic Use in Long-Term care (HALT): A single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia', International Psychogeriatrics, 29, pp. 1391 - 1403, http://dx.doi.org/10.1017/S1041610217000084
,2017, 'DEPRESCRIBING ANTIPSYCHOTICS IN LONG TERM CARE RESIDENTS WITH NEUROPSYCHIATRIC SYMPTOMS AND DEMENTIA', Innovation in Aging, 1, pp. 1066 - 1066, http://dx.doi.org/10.1093/geroni/igx004.3903
,2017, 'INAPPROPRIATE PRESCRIBING OF ANTIPSYCHOTIC MEDICATIONS IN LONG TERM-CARE RESIDENTS: THE HALT PROJECT', Innovation in Aging, 1, pp. 968 - 968, http://dx.doi.org/10.1093/geroni/igx004.3495
,2016, 'O2‐14‐01: Deprescribing Antipsychotics in Long‐Term Care Residents with Behavioral and Psychological Symptoms of Dementia', Alzheimer's & Dementia, 12, http://dx.doi.org/10.1016/j.jalz.2016.06.472
,2014, 'P3‐276: REDUCING INAPPROPRIATE USE OF ANTIPSYCHOTIC MEDICATION THROUGH CLINICIAN EDUCATION AND NON‐PHARMACOLOGICAL MANAGEMENT OF BPSD', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.05.1368
,2012, 'Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks', Cell Proliferation, 45, pp. 266 - 278, http://dx.doi.org/10.1111/j.1365-2184.2012.00813.x
,2011, 'GSK-3β Inhibition Promotes Engraftment of Ex Vivo-Expanded Hematopoietic Stem Cells and Modulates Gene Expression', Stem Cells, 29, pp. 108 - 118, http://dx.doi.org/10.1002/stem.551
,2008, 'Glycogen synthase kinase-3 beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth', Stem Cells, 26, pp. 1288 - 1297
,2008, 'siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth.', International Journal of Oncology, 33, pp. 175 - 183
,2008, 'The role of glycogen synthase kinase-3 beta in normal haematopoiesis, angiogenesis and leukaemia', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 15, pp. 1493 - 1499
,